Citations

Mayo Clinic

Showing 10 of 108551 citations.

Cardiac Rehabilitation — Challenges, Advances, and the Road Ahead
Thomas, Randal J.

New England Journal of Medicine | February 28, 2024 | Volume: 390 | Issue: 9 | Pages: 830-841

10.1056/nejmra2302291 | PMID 38416431 Get It

Efficacy of vedolizumab during intravenous induction therapy in ulcerative colitis and Crohn’s disease: post hoc analysis of patient-reported outcomes from the VISIBLE 1 and 2 studies
D’Haens, Geert , Baert, Filip , Kobayashi, Taku , Sandborn, William J. , Dornic, Quentin, Lindner, Dirk , Kisfalvi, Krisztina, Marins, Ed G. , Vermeire, Séverine , Kobayashi, Taku , Vermeire, Séverine , Danese, Silvio , Loftus, Edward V. , Lindner, Dirk

European Journal of Gastroenterology & Hepatology | February 28, 2024 | Volume: 36 | Issue: 4 | Pages: 404-415

10.1097/meg.0000000000002728 | PMID 38417060 Get It

Background Vedolizumab is an anti-α4β7 integrin antibody used to treat moderate to severe ulcerative colitis (UC) and Crohn’s disease (CD). This post hoc analysis of patient-reported outcomes (PROs) from the VISIBLE 1 (NCT02611830) and 2 (NCT02611817) phase 3 studies evaluated onset of treatment effect on patient-reported symptoms during 6-week vedolizumab induction. Methods Patient-reported stool frequency (SF) and rectal bleeding (RB) (UC Mayo score), and SF and abdominal pain (AP) in CD were collected via electronic diary from VISIBLE patients receiving one or more open-label intravenous (IV) vedolizumab induction doses (weeks 0 and 2). PRO data were analyzed using descriptive statistics. Results Data from 994 patients (UC 383, CD 611) showed mean ratings for all PROs declined consistently week-on-week from baseline through week 6, with early onset of improvement. By week 2, 22% of patients with UC reported RB improvement (≥1-point reduction in RB subscore, 7-day mean), rising to 45% by week 6. By week 6, 18% of patients with UC achieved SF improvement (SF subscore 0; 21% antitumor necrosis factor alpha [anti-TNFα] naive, 13% anti-TNFα experienced). SF improvement in patients with CD (reduction of ≥3 stools, 7-day mean) was achieved by 32% at week 6 (34% anti-TNFα naive, 30% anti-TNFα experienced). Fewer patients with CD reported severe/moderate AP at week 6 (5.1%/28.5%) than baseline (14.6%/61.5%). SF decline appeared greater and faster for anti-TNFα-naive vs. anti-TNFα-experienced patients (UC and CD). Conclusion Results indicate early onset of patient-reported UC and CD symptom improvement during vedolizumab IV induction in VISIBLE 1 and 2.
Genetic correlations of alcohol consumption and alcohol use disorder with sex hormone levels in females and males
Waller, Cameron, Ho, Ada Man‐Choi , Batzler, Anthony , Geske, Jennifer R. , Ho, Ada, Geske, Jennifer, Winham, Stacey, Ho, Ada M-C , Geske, Jennifer , Karpyak, Victor M. , Biernacka, Joanna M. , Winham, Stacey J.

No container title available | February 28, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-3944066/v1 | PMID 38464231 Get It

Abstract Background Alcohol consumption behaviors and alcohol use disorder risk and presentation differ by sex, and these complex traits are associated with blood concentrations of the steroid sex hormones, testosterone and estradiol, and their regulatory binding proteins, sex hormone binding globulin (SHBG) and albumin. Genetic variation is associated with alcohol consumption and alcohol use disorder, as well as levels of steroid sex hormones and their binding proteins. Methods To assess the contribution of genetic factors to previously described phenotypic associations between alcohol-use traits and sex-hormone levels, we estimated genetic correlations (rg) using summary statistics from prior published, large sample size genome-wide association studies (GWAS) of alcohol consumption, alcohol dependence, testosterone, estradiol, SHBG, and albumin. Results For alcohol consumption, we observed positive genetic correlation (i.e. genetic effects in the same direction) with total testosterone in males (rg = 0.084, p = 0.007) and trends toward positive genetic correlation with bioavailable testosterone (rg = 0.060, p = 0.084) and SHBG in males (rg = 0.056, p = 0.086) and with albumin in a sex-combined cohort (rg = 0.082, p = 0.015); however in females, we observed positive genetic correlation with SHBG (rg = 0.089, p = 0.004) and a trend toward negative genetic correlation (i.e. genetic effects in opposite directions) with bioavailable testosterone (rg = -0.064, p = 0.032). For alcohol dependence, we observed a trend toward negative genetic correlation with total testosterone in females (rg = -0.106, p = 0.024) and positive genetic correlation with BMI-adjusted SHBG in males (rg = 0.119, p = 0.017). Several of these genetic correlations differed between females and males and were not in the same direction as the corresponding phenotypic associations. Conclusions Findings suggest that shared genetic effects may contribute to positive associations of alcohol consumption with albumin in both sexes, as well as positive associations between alcohol consumption and bioavailable testosterone and between alcohol dependence and SHBG in males. However, relative contributions of heritable and environmental factors to associations between alcohol-use traits and sex-hormone levels may differ by sex, with genetic factors contributing more in males and environmental factors contributing more in females.
A Mixed-Method Approach to Explore Successful Recruitment and Treatment of Minority Patients on Therapeutic Cancer Clinical Trials at a Tertiary Referral Center Using Photo-Elicitation Interviews
Price, Katharine A. , Warsame, Rahma , O’Shea, Mary, Ellingson, Sara A., Asiedu, Gladys B. , Price, Katharine A R , Kim, Yong-Hun

Health Equity | February 28, 2024 | Volume: 8 | Issue: 1 | Pages: 117-127

10.1089/heq.2023.0170 | PMID 38435027 Get It

Teaching and Assessing Bedside Procedures: A Standardized Cross-Disciplinary Framework for Graduate Medical Education
Vohra, Taher , Kinni, Harish , Gardner-Gray, Jayna, Giles, Christopher, Hamam, Mohamed , Folt, Jason , Giles, Christopher D

Academic Medicine | February 28, 2024 | Volume: 99 | Issue: 3 | Pages: 266-272

10.1097/acm.0000000000005574 | PMID 38039977 Get It

Abstract Performing bedside procedures requires knowledge, reasoning, physical adeptness, and self-confidence; however, no consensus on a specific, comprehensive strategy for bedside procedure training and implementation is available. Bedside procedure training and credentialing processes across large institutions may vary among departments and specialties, leading to variable standards, creating an environment that lacks consistent accountability, and making quality improvement difficult. In this Scholarly Perspective, the authors describe a standardized bedside procedure training and certification process for graduate medical education with a common, institution-wide educational framework for teaching and assessing the following 7 important bedside procedures: paracentesis; thoracentesis; central venous catheterization; arterial catheterization; bladder catheterization or Foley catheterization; lumbar puncture; and nasogastric, orogastric, and nasoenteric tube placement. The proposed framework is a 4-stage process that includes 1 preparatory learning stage with simulation practice for knowledge acquisition and 3 clinical stages to guide learners from low-risk to high-risk practice and from high to low supervision. The pilot rollout took place at Henry Ford Hospital from December 2020 to July 2021 for 165 residents in the emergency medicine and/or internal medicine residency programs. The program was fully implemented institution-wide in July 2021. Assessment strategies encompass critical action checklists to confirm procedural understanding and a global rating scale to measure performance quality. A major aim of the bedside procedure training and certification was to standardize assessments so that physician trainers from multiple specialties could train, assess, and supervise any participating trainee, regardless of discipline. The authors list considerations revealed from the pilot rollout regarding electronic tracking systems and several benefits and implementation challenges to establishing institution-wide standards. The proposed framework was assembled by a multidisciplinary physician task force and will assist other institutions in adopting best approaches for training physicians in performing these critically important and difficult-to-perform procedures.
Large Defect Involving the Central Cutaneous and Mucosal Upper Lip
Wang, Katherine , Degesys, Catherine A. , Barbosa, Naiara S. , Wang, Katherine L

Dermatologic Surgery | February 28, 2024 | Volume: 50 | Issue: 11 | Pages: 1065-1067

10.1097/dss.0000000000004136 | PMID 38416812 Get It

Single-cell herpes simplex virus type 1 infection of neurons using drop-based microfluidics reveals heterogeneous replication kinetics
Fredrikson, Jacob P. , Domanico, Luke F. , Pratt, Shawna L. , Loveday, Emma K. , Taylor, Matthew P. , Chang, Connie B. , Loveday, Emma Kate , Chang, Connie B , Taylor, Matthew P

Science Advances | February 28, 2024 | Volume: 10 | Issue: 9 | Pages: No page available

10.1126/sciadv.adk9185 | PMID 38416818 Get It

Single-cell analyses of viral infections reveal heterogeneity that is not detected by traditional population-level studies. This study applies drop-based microfluidics to investigate the dynamics of herpes simplex virus type 1 (HSV-1) infection of neurons at the single-cell level. We used micrometer-scale Matrigel beads, termed microgels, to culture individual murine superior cervical ganglia (SCG) neurons or epithelial cells. Microgel-cultured cells are encapsulated in individual media-in-oil droplets with a dual–fluorescent reporter HSV-1, enabling real-time observation of viral gene expression and replication. Infection within drops revealed that the kinetics of initial viral gene expression and replication were dependent on the inoculating dose. Notably, increasing inoculating doses led to earlier onset of viral gene expression and more frequent productive viral replication. These observations provide crucial insights into the complexity of HSV-1 infection in neurons and emphasize the importance of studying single-cell outcomes of viral infection. These techniques for cell culture and infection in drops provide a foundation for future virology and neurobiology investigations.
Remote magnetic navigation enables precision telesurgery
Nelson, Bradley J. , Bendok, Bernard R. , Turcotte, Evelyn L. , Batjer, H. Hunt , Bendok, Bernard R , Nelson, Bradley J

Science Robotics | February 28, 2024 | Volume: 9 | Issue: 87 | Pages: No page available

10.1126/scirobotics.ado3187 | PMID 38416854 Get It

Medical devices actuated by external magnetic fields can create opportunities for clinical adoption of precision telesurgery.
Performance of CT With Adrenal-Washout Protocol in Heterogeneous Adrenal Nodules: A Multiinstitutional Study
Corwin, Michael T. , Caoili, Elaine M. , Elsayes, Khaled M. , Garratt, Joanie , Hackett, Caitlin E. , Mohd, Zahid, Sharbidre, Kedar , Yalon, Mariana , Navin, Patrick J. , Hudson, Emma, Mohd, Zahid, Shehata, Mostafa , Wang, Mindy X. , Wilson, Machelle , Remer, Erick M.

American Journal of Roentgenology | February 28, 2024 | Volume: 222 | Issue: 5 | Pages: No page available

10.2214/ajr.23.30769 | PMID 38415578 Get It

Identification of immune cell markers associated with ulcerative colitis histological disease activity in colonic biopsies
Lefèvre, Pavine, Wang, Zhongya , Teft, Wendy A., Viegen, Tanja van, Linggi, Bryan, Jairath, Vipul , Feagan, Brian G. , Pai, Rish K. , Jairath, Vipul , Jairath, Vipul , Jairath, V , Jairath, V , Jairath, Vipul , Zou, Guangyong , Casteele, Niels Vande

Journal of Clinical Pathology | February 28, 2024 | Volume: 78 | Issue: 9 | Pages: 605-613

10.1136/jcp-2023-209327 | PMID 38418201 Get It

Aims Accurate determination of histological activity in ulcerative colitis (UC) is essential given its diagnostic and prognostic importance. Data on the relationship between histology and immune cell markers are limited. We aimed to evaluate the association between histological disease activity and immune cell marker concentration in colonic biopsies from patients with UC. Methods Sigmoid colon biopsies from 20 patients with UC were retrospectively assessed using the Robarts Histopathology Index (RHI). Targeted mass spectrometry determined the concentration of 18 immune cell markers (cluster of differentiation (CD) 4, CD8, CD19, CD20, CD40, CD56, CD68, CD103, forkhead box p3 (FOXP3), human leucocyte antigen, DR alpha chain (HLA-DRA), interleukin 10 (IL-10), IL-23 subunit alpha (IL-23A), IL-23 receptor (IL-23R), IL-2 receptor alpha chain (IL-2RA), Ki67, lymphocyte-activation gene 3 (LAG-3), programmed cell death protein 1 (PD-1) and PD ligand 1 (PD-L1)). The association between RHI score and immune cell marker concentration was quantified using Spearman’s rank correlation coefficient (ρ) and related 95% CIs. Results Fourteen of the 18 immune cell marker proteins were detected, with tissue concentration ranging from 0.003 to 11.53 fmol/µg. The overall RHI score was positively correlated with CD19, CD20, CD40, FOXP3, LAG-3, PD-1 and PD-L1 concentration (ρ=0.596–0.799) and negatively correlated with CD56 concentration (ρ=−0.460). There was no significant association between RHI score and CD4, CD8, CD68, CD103, HLA-DRA or Ki67 concentration. Conclusions This study provides insight into the correlation between immune cell marker expression and histological disease activity and the possible molecular and immunological determinants underlying microscopic disease activity in UC.